Vaxcyte, Inc.PCVXNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank50
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P50
Within normal range
vs 5Y Ago
-35.5x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-40.89%
2024-30.27%
2023-106.68%
2022-37.90%
2021-167.77%
20201.15%
2019-49.94%
2018-199096.79%
20170.00%